deoxyepinephrine has been researched along with Necrotizing Pyelonephritis in 1 studies
Deoxyepinephrine: Sympathomimetic, vasoconstrictor agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ibopamine treatment was ineffective in Group 2, while in Group 1 patients there was a statistically significant increase in creatinine clearance (+23% after 3 months, +31% after 6 months)." | 2.65 | Long-term treatment of chronic renal insufficiency with Ibopamine (SB 7505), a new orally active dopamine-related drug. ( Colí, L; Docci, D; Mosconi, G; Prandini, R; Stefoni, S; Vangelista, A, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stefoni, S | 1 |
| Docci, D | 1 |
| Vangelista, A | 1 |
| Mosconi, G | 1 |
| Colí, L | 1 |
| Prandini, R | 1 |
1 trial available for deoxyepinephrine and Necrotizing Pyelonephritis
| Article | Year |
|---|---|
Long-term treatment of chronic renal insufficiency with Ibopamine (SB 7505), a new orally active dopamine-related drug.
Topics: Administration, Oral; Adult; Aged; Chronic Disease; Clinical Trials as Topic; Creatinine; Deoxyepine | 1982 |